InvestorsObserver
×
News Home

Where Will Tempest Therapeutics Inc (TPST) Stock Go Next After It Is Up 16.27% in a Week?

Monday, March 18, 2024 02:00 PM | InvestorsObserver Analysts

Mentioned in this article

Where Will Tempest Therapeutics Inc (TPST) Stock Go Next After It Is Up 16.27% in a Week?

Overall market sentiment has been high on Tempest Therapeutics Inc (TPST) stock lately. TPST receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
Tempest Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TPST!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With TPST Stock Today?

Tempest Therapeutics Inc (TPST) stock is trading at $3.93 as of 1:59 PM on Monday, Mar 18, a rise of $0.29, or 8.09% from the previous closing price of $3.64. The stock has traded between $3.64 and $4.08 so far today. Volume today is more active than usual. So far 812,524 shares have traded compared to average volume of 581,442 shares. To see InvestorsObserver's Sentiment Score for Tempest Therapeutics Inc click here.

More About Tempest Therapeutics Inc

Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Click Here to get the full Stock Report for Tempest Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App